NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/22/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,399.08 mln
Float104 mln
Earnings Date08/18/2026
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.37
Borderline
Relative Strength
18
/ 100
Significantly lagging
Debt / Equity
0.74
Moderate leverage
Pre-Tax Margin
6%
Low margin
ROE
28.35
Strong
Business Description
Caris Life Sciences is a US-based healthcare company that uses advanced genetic analysis and artificial intelligence to help doctors make better cancer treatment decisions. Founded in 2008 and based in Irving, Texas, the company offers a range of tools that examine tumor and blood samples to identify the molecular characteristics of a patient's cancer. These insights help match patients with the most effective therapies and can even detect cancer at an early stage. Caris also partners with pharmaceutical companies, providing research and data services to support the development of new treatments.
